FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022144597> ?p ?o ?g. }

• W3022144597 endingPage "351" @default.
• W3022144597 startingPage "331" @default.
• W3022144597 abstract "Vemurafenib (Zelboraf, Hoffmann-La Roche) is a selective serine/threonine kinase inhibitor that targets BRAF mutations, and in particular BRAFV600E (IC50 10 nM). Other BRAF mutations, such as V600K, V600D, V600R, V600G, V600M, and V600A, are also strongly inhibited (IC50 7–14 nM). It also exhibits IC50 values against SRMS (18 nM), ACK1 (19 nM), CRAF (48 nM), ARAF (48 nM), MAP4K5 (51 nM), and FGR (63 nM) at similar or moderately higher concentrations. BRAF mutations are constitutively activated, and frequently associated with a number of solid tumors, including melanoma. In 2011, the Food and Drug Administration (FDA) granted approval for the treatment of patients with malignant unresectable or metastatic melanoma (MM) with the BRAF-V600E mutation, as detected by a specific test (Cobas 4800 BRAF V600 Mutation Test). The European Medicines Agency (EMA) also granted accelerated approval in 2012 for the marketing of vemurafenib for the treatment of MM with any BRAFV600 mutation. The initial safety profile of vemurafenib was based on results from Studies PLX06-02, NP22657, and NO25026, and the ISS database of 524 patients treated with vemurafenib, including 500 subjects with MM. In the outcome of the EMA assessment report, the safety population was 866 patients who received at least one dose of vemurafenib (584) or dacarbazine (282). The typical safety profile, as depicted in MM patients, is generally considered moderate, and is characterized by arthralgia, fatigue, and cutaneous disorders including rash, photosensitivity reactions, and keratotic hyper/dysproliferative conditions, followed by diarrhea, other gastrointestinal disorders, and a number of constitutional signs. More concerning events were represented by squamous cell carcinoma (mostly cuSCC), other secondary malignancies including new melanocytic tumors, QT interval prolongation, and severe liver disorders." @default.
• W3022144597 created "2020-05-13" @default.
• W3022144597 creator A5001706013 @default.
• W3022144597 date "2017-01-01" @default.
• W3022144597 modified "2023-09-24" @default.
• W3022144597 title "Vemurafenib" @default.
• W3022144597 cites W1215179222 @default.
• W3022144597 cites W1491720556 @default.
• W3022144597 cites W1517775419 @default.
• W3022144597 cites W1559286003 @default.
• W3022144597 cites W1570494660 @default.
• W3022144597 cites W1576116802 @default.
• W3022144597 cites W1963976650 @default.
• W3022144597 cites W1969179779 @default.
• W3022144597 cites W1969870912 @default.
• W3022144597 cites W1970293698 @default.
• W3022144597 cites W1970845550 @default.
• W3022144597 cites W1971947883 @default.
• W3022144597 cites W1974063494 @default.
• W3022144597 cites W1978653625 @default.
• W3022144597 cites W1981449639 @default.
• W3022144597 cites W1983338675 @default.
• W3022144597 cites W1986426976 @default.
• W3022144597 cites W1987622297 @default.
• W3022144597 cites W1989121777 @default.
• W3022144597 cites W1990211334 @default.
• W3022144597 cites W1990572783 @default.
• W3022144597 cites W1994631083 @default.
• W3022144597 cites W2000581759 @default.
• W3022144597 cites W2001710734 @default.
• W3022144597 cites W2004015477 @default.
• W3022144597 cites W2004295816 @default.
• W3022144597 cites W2004567448 @default.
• W3022144597 cites W2005278507 @default.
• W3022144597 cites W2006268804 @default.
• W3022144597 cites W2009687824 @default.
• W3022144597 cites W2011780255 @default.
• W3022144597 cites W2012563874 @default.
• W3022144597 cites W2012957572 @default.
• W3022144597 cites W2013392744 @default.
• W3022144597 cites W2013518159 @default.
• W3022144597 cites W2014565000 @default.
• W3022144597 cites W2014881369 @default.
• W3022144597 cites W2014912105 @default.
• W3022144597 cites W2017187984 @default.
• W3022144597 cites W2019060733 @default.
• W3022144597 cites W2023274353 @default.
• W3022144597 cites W2023356502 @default.
• W3022144597 cites W2024085992 @default.
• W3022144597 cites W2025130458 @default.
• W3022144597 cites W202542274 @default.
• W3022144597 cites W2026160531 @default.
• W3022144597 cites W2027263063 @default.
• W3022144597 cites W2033110631 @default.
• W3022144597 cites W2038595087 @default.
• W3022144597 cites W2040956995 @default.
• W3022144597 cites W2043058822 @default.
• W3022144597 cites W2051923761 @default.
• W3022144597 cites W2052771542 @default.
• W3022144597 cites W2052781279 @default.
• W3022144597 cites W2056162873 @default.
• W3022144597 cites W2056772575 @default.
• W3022144597 cites W2058261026 @default.
• W3022144597 cites W2060573548 @default.
• W3022144597 cites W2064294486 @default.
• W3022144597 cites W2066500792 @default.
• W3022144597 cites W2069682021 @default.
• W3022144597 cites W2070647418 @default.
• W3022144597 cites W2071668988 @default.
• W3022144597 cites W2071990670 @default.
• W3022144597 cites W2073713419 @default.
• W3022144597 cites W2075608121 @default.
• W3022144597 cites W2078570874 @default.
• W3022144597 cites W2079216025 @default.
• W3022144597 cites W2080541203 @default.
• W3022144597 cites W2081511916 @default.
• W3022144597 cites W2083251207 @default.
• W3022144597 cites W2087370251 @default.
• W3022144597 cites W2091100650 @default.
• W3022144597 cites W2092383314 @default.
• W3022144597 cites W2093291977 @default.
• W3022144597 cites W2095312392 @default.
• W3022144597 cites W2096024381 @default.
• W3022144597 cites W2096645965 @default.
• W3022144597 cites W2096849837 @default.
• W3022144597 cites W2097095323 @default.
• W3022144597 cites W2099356406 @default.
• W3022144597 cites W2101621182 @default.
• W3022144597 cites W2103228883 @default.
• W3022144597 cites W2103675014 @default.
• W3022144597 cites W2104562394 @default.
• W3022144597 cites W2106451155 @default.
• W3022144597 cites W2106543129 @default.
• W3022144597 cites W2107224559 @default.
• W3022144597 cites W2107421779 @default.
• W3022144597 cites W2109691986 @default.
• W3022144597 cites W2111404068 @default.
• W3022144597 cites W2115424172 @default.

• next